Collier S, Ghosh P
Raymond Purves Research Laboratories, University of Sydney, Royal North Shore Hospital, St Leonards, NSW, Australia.
Ann Rheum Dis. 1989 May;48(5):372-81. doi: 10.1136/ard.48.5.372.
A new method is described for separating free 35SO4-- from 35SO4 labelled proteoglycans synthesised by rabbit articular chondrocytes cultured in the presence of excess 35SO4--. The procedure uses the low solubility product of barium sulphate to remove, by precipitation, free 35SO4-- from culture medium. Optimum recovery of 35SO4 labelled proteoglycans was achieved after papain digestion to release 35SO4-glycosaminoglycans, and addition of chondroitin sulphate before the precipitation step. Using this assay, we studied the effect of six drugs-indomethacin, diclofenac, sodium pentosan polysulphate, glycosaminoglycan polysulphate ester, tiaprofenic acid, and ketoprofen-on the secretion into the medium of labelled proteoglycans by lapine chondrocytes. The six drugs were tested at 0.1, 1, 10, 50, and 100 micrograms/ml over four consecutive 48 hour culture periods. A consistent concentration-response pattern was found for the four non-steroidal anti-inflammatory drugs (NSAIDs) studied. Generally they inhibited proteoglycan secretion at 50 and 100 micrograms/ml but had no effect at lower concentrations. Inhibition of secretion was strongest with indomethacin and diclofenac at 50 and 100 micrograms/ml. In contrast with the NSAIDs studied, the two sulphated polysaccharides (sodium pentosan polysulphate and glycosaminoglycan polysulphate ester) at low concentrations increased proteoglycan secretion by chondrocytes, with maximal stimulation occurring at 1 microgram/ml. Sodium pentosan polysulphate, but not glycosaminoglycan polysulphate ester, showed inhibitory activity at 50 and 100 micrograms/ml.
本文描述了一种新方法,用于从在过量35SO4--存在下培养的兔关节软骨细胞合成的35SO4标记蛋白聚糖中分离游离35SO4--。该方法利用硫酸钡的低溶解度产物,通过沉淀从培养基中去除游离35SO4--。在木瓜蛋白酶消化释放35SO4-糖胺聚糖并在沉淀步骤前添加硫酸软骨素后,实现了35SO4标记蛋白聚糖的最佳回收率。使用该测定法,我们研究了六种药物——吲哚美辛、双氯芬酸、戊聚糖多硫酸钠、糖胺聚糖多硫酸酯、噻洛芬酸和酮洛芬——对兔软骨细胞向培养基中分泌标记蛋白聚糖的影响。在连续四个48小时的培养期内,以0.1、1、10、50和100微克/毫升的浓度测试了这六种药物。在所研究的四种非甾体抗炎药(NSAIDs)中发现了一致的浓度-反应模式。一般来说,它们在50和100微克/毫升时抑制蛋白聚糖分泌,但在较低浓度时没有作用。吲哚美辛和双氯芬酸在50和100微克/毫升时对分泌的抑制作用最强。与所研究的NSAIDs不同,两种硫酸化多糖(戊聚糖多硫酸钠和糖胺聚糖多硫酸酯)在低浓度时增加了软骨细胞的蛋白聚糖分泌,最大刺激发生在1微克/毫升。戊聚糖多硫酸钠在50和100微克/毫升时显示出抑制活性,而糖胺聚糖多硫酸酯则没有。